From Targeted Oncology: 'Dr Mikhael on the State of Myeloma Research Funding in 2025'

Federal funding cuts could slow the remarkable progress seen in multiple myeloma treatments, yet unprecedented collaboration among researchers keeps hope alive. In this interview with Targeted Oncology, Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, shares his candid concerns and his optimism for the future.